Table 2.
PCR primers used in these studies.
| PCR Primers | ||
|---|---|---|
| FAIRE and ChIP Primers | ||
| Locus | Forward Sequence (5’-3’) | Reverse Sequence (5’-3’) |
| P1 (screening site) | AAGGAAGGAAGGGAGGGACACATAC | CCTGTGAGTGTGACAGATTACTTGG |
| P7 (screening site) | GGGTGACAGAGTAAGATCCTGTCAGA | TGGGCGTGGTTCTCATGT |
| AURKAIP1 (+ control) | TATACCCGCAGGTCCAGAATCGTT | AATAGCTCTAGACGCTTCCGCCTT |
| BC006361 (- control) | TTCTCCAACTTTGGAAGCCCAGGA | TGTCTCCTTCTAGGCCCTCACAAT |
| JAK1 | GGGAGGAATTGAAAGGAAGTGTGT | TGTGAAACCTCGTCTGATCCACCCT |
| NR0B1 | GCATCAGGAAGCCTGGATCCATTA | GTATATACCAACACCCTTCCCTG |
| CAV1 | AAGGAAGGAAGGAAGACCCT | GTACAACGAATCCCTGTGACACAAA |
| MDM2 | TGGATCTGAGGAGGAAATGTGCGT | TAACTCATCCCTGTGCCTCTGCT |
| JAK1.2 | GGAGACAGGCTCCAACACAGGAAA | AAGTATCCCTCAAGTTGCCCTGCT |
| NKX2-2 | TCTCTCCTTTCCATCGTTGGTGGT | AGCACTCATCCTTAAGCCTCAACC |
| Negative Site 1 | TGGATGCACAGAGAATGTCCACCT | TGGTTCGTAAGTGACAGAGCCAGA |
| Expression Primers | ||
| Target | Forward Sequence (5’-3’) | Reverse Sequence (5’-3’) |
| EWS-FLI | GCTATGGTCAACAAAGCAGCTATG | TTGGCTAGGCGACTGCTGGT |
| GAPDH | CTGACTTCAACAGCGACACC | TAGCCAAATTCGTTGTCATACC |